Australia's ambitious lung cancer screening program has been operational for a year, but the real challenge lies in ensuring the health system can effectively follow through on the screening results. While the program's goal is commendable, addressing critical concerns is essential to achieving its full potential.
The Screening Program: A Step Towards Early Detection
The National Lung Cancer Screening Program utilizes low-dose CT scans to identify lung cancer in high-risk individuals without symptoms. It targets people aged 50-70 who currently smoke or have quit in the past decade, with a smoking history of at least 30 pack-years. The program's logic is straightforward: early detection increases the chances of a cure and reduces deaths from a disease that claims more lives than breast and bowel cancer combined. In 2025, over 15,000 Australians were diagnosed with lung cancer, making early detection crucial.
Challenges Beyond Screening
However, screening is just the beginning. The real challenge is ensuring the health system can efficiently transition from suspicion to diagnosis and treatment. Australia faces gaps in lung cancer services, including shortages of specialist nurses, incomplete multidisciplinary teams, and unequal access to diagnostics and personalized medicine. A recent survey revealed that only 40% of institutions have the recommended core workforce for multidisciplinary lung cancer team meetings, and around 25% lack specialist lung cancer nurses.
The impact of these shortages is particularly severe in regional and remote areas, where patients face longer travel times, extended waits, and slower treatment routes. This issue is especially concerning for Aboriginal and Torres Strait Islander peoples, who bear a disproportionate burden of lung cancer. The program's co-design with Cancer Australia and the National Aboriginal Community Controlled Health Organisation is a positive step, but ensuring cultural safety, timely follow-up, and proper support for community-controlled services are crucial.
Missing Link: Smoking Cessation Support
Another missed opportunity lies in combining screening with smoking cessation support. Quitting smoking around the time of screening offers significant short- and long-term benefits, and people are more open to quitting during this period. However, the screening program lacks a Medicare Benefits Schedule item number to support and fund this crucial aspect, potentially reducing health professionals' ability to provide adequate smoking cessation support.
Data Gaps and Coordination Issues
Furthermore, Australia needs better nationally collected data to assess the program's effectiveness and identify areas for improvement. Currently, different hospitals use varying quality indicators, making comparisons and real-time feedback challenging. Without addressing these data gaps and coordination issues, the program may detect early-stage lung cancer but fail to provide timely and coordinated treatment, perpetuating fragmented care and avoidable disparities in outcomes and survival.
